First Trust Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-217,558
| Closed | -$3.12M | – | 2627 |
|
|
2024
Q4 | $3.12M | Buy |
217,558
+133,841
| +160% | +$1.92M | ﹤0.01% | 1620 |
|
|
2024
Q3 | $1.89M | Buy |
83,717
+73,624
| +729% | +$1.66M | ﹤0.01% | 1793 |
|
|
2024
Q2 | $196K | Sell |
10,093
-569,791
| -98% | -$11.1M | ﹤0.01% | 2255 |
|
|
2024
Q1 | $21.8M | Buy |
579,884
+565,532
| +3,940% | +$21.2M | 0.02% | 764 |
|
|
2023
Q4 | $803K | Sell |
14,352
-229,588
| -94% | -$12.8M | ﹤0.01% | 2032 |
|
|
2023
Q3 | $10.1M | Sell |
243,940
-26,929
| -10% | -$1.11M | 0.01% | 982 |
|
|
2023
Q2 | $15.1M | Buy |
270,869
+264,247
| +3,990% | +$14.8M | 0.02% | 875 |
|
|
2023
Q1 | $369K | Buy |
6,622
+362
| +6% | +$20.2K | ﹤0.01% | 2198 |
|
|
2022
Q4 | $228K | Sell |
6,260
-2,581
| -29% | -$94.1K | ﹤0.01% | 2354 |
|
|
2022
Q3 | $252K | Sell |
8,841
-1,463
| -14% | -$41.7K | ﹤0.01% | 2366 |
|
|
2022
Q2 | $466K | Sell |
10,304
-25,797
| -71% | -$1.17M | ﹤0.01% | 2219 |
|
|
2022
Q1 | $2.75M | Sell |
36,101
-75,566
| -68% | -$5.75M | ﹤0.01% | 1646 |
|
|
2021
Q4 | $16.6M | Sell |
111,667
-240,512
| -68% | -$35.8M | 0.02% | 904 |
|
|
2021
Q3 | $51.3M | Buy |
352,179
+37,268
| +12% | +$5.43M | 0.06% | 454 |
|
|
2021
Q2 | $61.7M | Buy |
314,911
+57,735
| +22% | +$11.3M | 0.07% | 397 |
|
|
2021
Q1 | $46.5M | Sell |
257,176
-58,418
| -19% | -$10.6M | 0.06% | 453 |
|
|
2020
Q4 | $44.7M | Buy |
315,594
+266,253
| +540% | +$37.7M | 0.06% | 443 |
|
|
2020
Q3 | $6.15M | Buy |
+49,341
| New | +$6.15M | 0.01% | 896 |
|